All Posts: non-small cell lung cancer

• Investigational Drug Shows Promise in a Clinical Trial for Lung Cancers With ALK Mutations

  Early signals from phase 1 of the ALKOVE-1 clinical trial suggest potential benefit from the use of an investigational drug called NVL-655 in people whose non-small cell lung cancer has alterations in a gene called ALK.

  Category: News Release Tags: cancer, clinical trials, gene sequencing, Georgetown Lombardi, non-small cell lung cancer, research